367 related articles for article (PubMed ID: 26696207)
21. The diagnostic accuracy of the immunocytochemical markers in the pre-operative evaluation of follicular thyroid lesions.
Raggio E; Camandona M; Solerio D; Martino P; Franchello A; Orlandi F; Gasparri G
J Endocrinol Invest; 2010 Jun; 33(6):378-81. PubMed ID: 19625759
[TBL] [Abstract][Full Text] [Related]
22. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
Eszlinger M; Paschke R
Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
[TBL] [Abstract][Full Text] [Related]
23. Application of chemokine CXC motif ligand 12 as a novel diagnostic marker in preoperative fine-needle aspiration biopsy for papillary thyroid carcinoma.
Jung YY; Park IA; Kim MA; Min HS; Won JK; Ryu HS
Acta Cytol; 2013; 57(5):447-54. PubMed ID: 24021782
[TBL] [Abstract][Full Text] [Related]
24. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.
Park YJ; Kwak SH; Kim DC; Kim H; Choe G; Park DJ; Jang HC; Park SH; Cho BY; Park SY
J Korean Med Sci; 2007 Aug; 22(4):621-8. PubMed ID: 17728499
[TBL] [Abstract][Full Text] [Related]
26. The significance of Galectin-3 expression in the immunocytochemical evaluation of thyroid fine needle aspiration cytology.
Ersoz S; Sert H; Yandi M; Erem C; Mungan S; Ersoz HO; Cobanoglu U; Hacihasanoglu A
Pathol Oncol Res; 2008 Dec; 14(4):457-60. PubMed ID: 18415710
[TBL] [Abstract][Full Text] [Related]
27. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
[TBL] [Abstract][Full Text] [Related]
28. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
Simms A; Jacob RP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
[TBL] [Abstract][Full Text] [Related]
29. Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
Brandler TC; Zhou F; Liu CZ; Cho M; Lau RP; Simsir A; Patel KN; Sun W
Cancer Cytopathol; 2017 Jun; 125(6):378-388. PubMed ID: 28296267
[TBL] [Abstract][Full Text] [Related]
30. [Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].
Cerutti JM
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):832-42. PubMed ID: 17891248
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China.
Song Q; Wang D; Lou Y; Li C; Fang C; He X; Li J
Diagn Pathol; 2011 Dec; 6():126. PubMed ID: 22188859
[TBL] [Abstract][Full Text] [Related]
32. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
Ouyang D; Chen FJ; Wei MW; Yang AK; Chen ZQ; Li QL; Chen YF
Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Accuracy of Fine Needle Aspiration in Thyroid Nodules Arising in Patients with Graves Disease.
Hang JF; Lilo MT; Bishop JA; Ali SZ
Acta Cytol; 2017; 61(2):117-124. PubMed ID: 28259878
[TBL] [Abstract][Full Text] [Related]
34. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase 4 and crystallin α-B immunoreactivity may distinguish benign from malignant thyroid nodules in patients with indeterminate thyroid cytology.
Davidov T; Nagar M; Kierson M; Chekmareva M; Chen C; Lu SE; Lin Y; Chernyavsky V; Potdevin L; Arumugam D; Barnard N; Trooskin S
J Surg Res; 2014 Aug; 190(2):565-74. PubMed ID: 24880201
[TBL] [Abstract][Full Text] [Related]
36. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
37. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
[TBL] [Abstract][Full Text] [Related]
38. Contribution of immunocytochemical stainings for galectin-3, CD44, and HBME1 to fine-needle aspiration cytology diagnosis of papillary thyroid carcinoma.
Das DK; Al-Waheeb SK; George SS; Haji BI; Mallik MK
Diagn Cytopathol; 2014 Jun; 42(6):498-505. PubMed ID: 24273003
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions.
Kim MJ; Kim HJ; Hong SJ; Shong YK; Gong G
Acta Cytol; 2006; 50(1):28-34. PubMed ID: 16514837
[TBL] [Abstract][Full Text] [Related]
40. Galectin-1 is a diagnostic marker involved in thyroid cancer progression.
Arcolia V; Journe F; Wattier A; Leteurtre E; Renaud F; Gabius HJ; Remmelink M; Decaestecker C; Rodriguez A; Boutry S; Laurent S; Saussez S
Int J Oncol; 2017 Sep; 51(3):760-770. PubMed ID: 28677745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
